The South Africa respiratory devices market is anticipated to expand at a CAGR of 6.8 % during the forecast period, 2021-2028. The growth of the market is attributed to the increasing burden of chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Moreover, increasing advancements in product technologies is expected to propel the market growth.
South Africa is ranked 25th worldwide in the number of asthma cases and is ranked fifth for asthma mortality, with an estimated 18 deaths per 100,000 asthma cases. The factors associated with asthma prevalence and other respiratory diseases in South Africa is due to the increasing adoption of urban lifestyle, which is coupled with conditions such as atopy, obesity, exposure to industrial pollution or tobacco smoke.
The report on the South Africa Respiratory Devices Market includes an assessment of the market, trends, segments and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
South Africa Respiratory Devices Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2020 |
Historic Data |
2018–2019 |
Forecast Period |
2021–2026 |
Segmentation |
Types (Diagnostic and Monitoring Devices [Spirometers, Sleep Test Devices, Peak Flow Meters, Pulse Oximeters, Capnographs and Others], Therapeutic Devices [CPAP Devices, BiPAP Devices, Humidifiers, Nebulizers, Oxygen Concentrators, Ventilators, Inhalers, Others], Disposables [Masks, Breathing Circuits, Other Disposables]) |
Geographic Zone |
South Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
Drägerwerk AG & Co. KGaA, GE Healthcare, Masimo, Invacare Corporation, Koninklijke Philips NV |
Based on types, the market is segregated into diagnostic and monitoring devices, therapeutic devices, and disposables. The diagnostic and monitoring devices segment is further divided into spirometers, sleep test devices, peak flow meters, pulse oximeters, capnographs, and others. The therapeutic devices segment is classified as CPAP devices, BiPAP devices, humidifiers, nebulizers, oxygen concentrators, ventilators, inhalers, others. The disposables segment is further divided into masks, breathing circuits, and others.
The diagnostic and monitoring devices segment is anticipated to account for a major market share during the forecast period. In this segment, the spirometers sub-segment is projected to account a significant market share in the projected timeline. Spirometers are used in pulmonary tests to measure the air inhaled and exhaled. They provide a simple way of measuring lung volume and capacity. ?These devices help in diagnosing respiratory diseases, such as asthma, emphysema, bronchitis, and COPD. They can also be used to assess shortness of breath, lung function before surgery, and the effect of medication. ?
The disposable masks segment is expected to account for a considerable market share during the forecast period. Government state bodies have implemented stringent rules on wearing masks to mitigate the spread of the virus. However, this segment is anticipated to grow at a moderate rate in the projected timeline.
Diagnostic and Monitoring Devices
Therapeutic Devices
Disposables
The major market players include Drägerwerk AG & Co. KGaA, GE Healthcare, Masimo, Koninklijke Philips NV, and Invacare Corporation.
The companies are engaging in strategies such as mergers, product launches, acquisition, and partnerships to leverage their market position.
Diagnostic and Monitoring Devices
Therapeutic Devices
Disposables
The major market players include Drägerwerk AG & Co. KGaA, GE Healthcare, Masimo, Koninklijke Philips NV, and Invacare Corporation.
The companies are engaging in strategies such as mergers, product launches, acquisition, and partnerships to leverage their market position.
Some other reports from this category!